GYRE Operating Cash Flow (Statement)
Gyre Therapeutics Inc · Operating Cash Flow (Statement)
GYRE Operating Cash Flow (Statement)
Latest reported-$16.73Mperiod ending
GYRE Quarterly Cash from Operations (-$7.00M → -$16.73M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
GYRE operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -16,728,000 | |
| 3,180,000 | |
| -5,625,000 | |
| 4,676,000 | |
| 2,088,000 | |
| -129,000 | |
| -2,758,000 | |
| 1,676,000 | |
| -5,612,000 | |
| 2,884,000 | |
| 3,360,000 | |
| 7,582,000 | |
| 4,533,000 | |
| 10,417,000 | |
| 42,298,000 | |
| -7,277,000 | |
| -12,294,000 | |
| 8,995,548 | |
| -17,676,000 | |
| -21,600,000 | |
| -20,123,000 | |
| -24,356,000 | |
| -22,114,000 | |
| -13,008,000 | |
| -15,136,000 | |
| -4,790,000 | |
| -8,089,000 | |
| -9,100,000 | |
| -11,466,000 | |
| -14,958,000 | |
| -9,011,000 | |
| -7,022,000 | |
| -7,413,000 | |
| -5,107,000 | |
| -6,317,000 | |
| -4,929,000 | |
| -4,402,000 | |
| -4,292,000 | |
| -4,977,000 | |
| -5,109,000 | |
| -3,642,000 | |
| -4,744,000 | |
| -5,142,000 | |
| -4,132,000 | |
| -5,397,000 | |
| -4,447,000 | |
| -3,052,000 | |
| -7,672,000 | |
| -8,913,000 | |
| -14,846,000 | |
| -11,168,000 | |
| -9,709,000 | |
| -10,415,000 | |
| -9,320,000 | |
| -11,601,000 | |
| -10,403,000 | |
| -17,335,000 | |
| -24,900,000 | |
| -20,529,000 | |
| -18,081,000 | |
| -23,063,000 | |
| -22,045,000 | |
| -15,714,000 | |
| -16,988,000 | |
| -3,349,000 | |
| 174,349,000 | |
| -11,727,000 | |
| 1,965,000 | |
| -6,721,000 | |
| -7,788,000 | |
| -4,828,276 | |
| -8,291,528 | |
| -8,424,107 | |
| -6,717,089 | |
| -39,471 | |
| 16,813,822 | |
| -6,099,747 | |
| 14,163,472 | |
| -4,343,966 | |
| -4,275,546 | |
| -4,081,246 | |
| 2,808,481 | |
| -5,589,046 | |
| -6,845,897 | |
| -6,814,141 | |
| -6,997,432 |